Patent · US Active

Combined methods for tumor coagulation and tumor treatment

US7691380B2 · kind B2 · utility

23Cited by

78References

69Claims

0Family size

Assignee

The Board of Regents of the University of Texas System · US

Inventors

Philip E. Thorpe · Dallas, US
Thomas S. Edgington · Village of La Jolla, US

Key dates

Filing date	Feb 27, 2003
Grant date	Apr 6, 2010
Priority date	—
Expiry date	Oct 5, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are various compositions and methods for use in achieving specific blood coagulation. This is exemplified by the specific in vivo coagulation of tumor vasculature, causing tumor regression, through the site-specific delivery of a coagulant using a bispecific antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.